Ganetespib (STA-9090)

ganetespib · Synta Pharmaceuticals Corp.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ganetespib (STA-9090), covering 2014-07-23 to 2014-07-23. Get the full timeline:

Most recent: Clinical Trial Update: PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer [Phase 2]